Microvesicles as risk markers for venous thrombosis

References

• Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch. Intern. Med. 158(6), 585–593 (1998).
   PubMed Web of Science ®Google Scholar
• Kahn SR, Lim W, Dunn AS et al.; American College of Chest Physicians. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(Suppl. 2), e195S–e226S (2012).
   PubMed Web of Science ®Google Scholar
• Owens AP 3rd, Mackman N. Microparticles in hemostasis and thrombosis. Circ. Res. 108(10), 1284–1297 (2011).
   PubMed Web of Science ®Google Scholar
• Morel O, Toti F, Hugel B et al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler. Thromb. Vasc. Biol. 26(12), 2594–2604 (2006).
   PubMed Web of Science ®Google Scholar
• Aleman MM, Gardiner C, Harrison P, Wolberg AS. Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. J. Thromb. Haemost. 9(11), 2251–2261 (2011).
   PubMed Web of Science ®Google Scholar
• Lacroix R, Dignat-George F. Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation. Thromb. Res. 129(Suppl. 2), S27–S29 (2012).
   PubMed Web of Science ®Google Scholar
• Lacroix R, Judicone C, Poncelet P et al. Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol. J. Thromb. Haemost. 10(3), 437–446 (2012).
   PubMed Web of Science ®Google Scholar
• van der Pol E, Hoekstra AG, Sturk A, Otto C, van Leeuwen TG, Nieuwland R. Optical and non-optical methods for detection and characterization of microparticles and exosomes. J. Thromb. Haemost. 8(12), 2596–2607 (2010).
   PubMed Web of Science ®Google Scholar
• Freyssinet JM, Toti F. Membrane microparticle determination: at least seeing what’s being sized! J. Thromb. Haemost. 8(2), 311–314 (2010).
   PubMed Web of Science ®Google Scholar
• Key NS, Mackman N. Tissue factor and its measurement in whole blood, plasma, and microparticles. Semin. Thromb. Hemost. 36(8), 865–875 (2010).
   PubMed Web of Science ®Google Scholar
• György B, Módos K, Pállinger E et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood 117(4), e39–e48 (2011).
   Web of Science ®Google Scholar
• Amabile N, Renard JM, Caussin C, Boulanger CM. Circulating immune complexes do not affect microparticle flow cytometry analysis in acute coronary syndrome. Blood 119(9), 2174–2175; author reply 2175 (2012).
   PubMedGoogle Scholar
• Zwicker JI, Trenor CC 3rd, Furie BC, Furie B. Tissue factor-bearing microparticles and thrombus formation. Arterioscler. Thromb. Vasc. Biol. 31(4), 728–733 (2011).
   PubMed Web of Science ®Google Scholar
• Yuana Y, Oosterkamp TH, Bahatyrova S et al. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles. J. Thromb. Haemost. 8(2), 315–323 (2010).
   PubMed Web of Science ®Google Scholar
• Aras O, Shet A, Bach RR et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 103(12), 4545–4553 (2004).
   PubMed Web of Science ®Google Scholar
• Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J. Thromb. Haemost. 5(3), 520–527 (2007).
   PubMed Web of Science ®Google Scholar
• Bates SM, Jaeschke R, Stevens SM et al. Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(Suppl. 2), e351S–418S (2012).
   PubMedGoogle Scholar
• Rautou PE, Vion AC, Amabile N et al. Microparticles, vascular function, and atherothrombosis. Circ. Res. 109(5), 593–606 (2011).
   PubMed Web of Science ®Google Scholar
• Rautou PE, Mackman N. Deletion of microvesicles from the circulation. Circulation 125(13), 1601–1604 (2012).
   PubMed Web of Science ®Google Scholar
• Zwicker JI, Liebman HA, Neuberg D et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin. Cancer Res. 15(22), 6830–6840 (2009).
   PubMed Web of Science ®Google Scholar
• Tesselaar ME, Romijn FP, van der Linden IK, Bertina RM, Osanto S. Microparticle-associated tissue factor activity in cancer patients with and without thrombosis. J. Thromb. Haemost. 7(8), 1421–1423 (2009).
   PubMed Web of Science ®Google Scholar
• Manly DA, Wang J, Glover SL et al. Increased microparticle tissue factor activity in cancer patients with venous thromboembolism. Thromb. Res. 125(6), 511–512 (2010).
   PubMed Web of Science ®Google Scholar
• Campello E, Spiezia L, Radu CM et al. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism. Thromb. Res. 127(5), 473–477 (2011).
   PubMed Web of Science ®Google Scholar
• Bucciarelli P, Martinelli I, Artoni A et al. Circulating microparticles and risk of venous thromboembolism. Thromb. Res. 129(5), 591–597 (2012).
   PubMed Web of Science ®Google Scholar
• Ye R, Ye C, Huang Y, Liu L, Wang S. Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis. Thromb. Res. 130(2), 253–258 (2012).
   PubMedGoogle Scholar
• Bharthuar A, Khorana AA, Hutson A, Wang J, Mackman N, Iyer RV. Association of elevated tissue factor (tf) with survival and thromboembolism (te) in pancreaticobiliary cancers (pbc). J. Clin. Oncol. 28, Abstract 4126 (2010).
   Google Scholar
• Ramacciotti E, Blackburn S, Hawley AE et al. Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis. Clin. Appl. Thromb. Hemost. 17(4), 425–431 (2011).
   PubMed Web of Science ®Google Scholar
• Flores-Nascimento MC, Beltrame MP, De Paula EV et al. Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden. Platelets 20(6), 367–375 (2009).
   PubMed Web of Science ®Google Scholar
• Garcia Rodriguez P, Eikenboom HC, Tesselaar ME et al. Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism. Thromb. Res. 126(4), 345–349 (2010).
   PubMedGoogle Scholar
• Khorana AA, Francis CW, Menzies KE et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J. Thromb. Haemost. 6(11), 1983–1985 (2008).
   PubMed Web of Science ®Google Scholar
• Auwerda JJ, Yuana Y, Osanto S et al. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma. Thromb. Haemost. 105(1), 14–20 (2011).
   PubMed Web of Science ®Google Scholar
• van Doormaal F, Kleinjan A, Berckmans RJ et al. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study. Thromb. Haemost. 108(1), 160–165 (2012).
   PubMed Web of Science ®Google Scholar
• Thaler J, Ay C, Mackman N et al. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J. Thromb. Haemost. 10(7), 1363–1370 (2012).
   PubMed Web of Science ®Google Scholar
• Ay C, Freyssinet JM, Sailer T, Vormittag R, Pabinger I. Circulating procoagulant microparticles in patients with venous thromboembolism. Thromb. Res. 123(5), 724–726 (2009).
   PubMedGoogle Scholar
• Bal L, Ederhy S, Di Angelantonio E et al. Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism. Arch. Cardiovasc. Dis. 103(6–7), 394–403 (2010).
   PubMedGoogle Scholar
• Steppich BA, Hassenpflug M, Braun SL et al. Circulating tissue factor and microparticles are not increased in patients with deep vein thrombosis. VASA. 40(2), 117–122 (2011).
   PubMedGoogle Scholar
• Sartori MT, Della Puppa A, Ballin A et al. Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. J. Neurooncol. 104(1), 225–231 (2011).
   PubMed Web of Science ®Google Scholar
• Owen BA, Xue A, Heit JA, Owen WG. Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism. Thromb. Res. 127(1), 39–46 (2011).
   PubMedGoogle Scholar
• Rectenwald JE, Myers DD Jr, Hawley AE et al. D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb. Haemost. 94(6), 1312–1317 (2005).
   PubMed Web of Science ®Google Scholar
• Chirinos JA, Heresi GA, Velasquez H et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J. Am. Coll. Cardiol. 45(9), 1467–1471 (2005).
   PubMed Web of Science ®Google Scholar
• Martínez M, Ricart JM, Ruiz-Aja S et al. Platelet activation and red blood cell phosphatidylserine exposure evaluated by flow cytometry in patients with Behçet’s disease: are they related to thrombotic events? Pathophysiol. Haemost. Thromb. 36(1), 18–22 (2007).
   PubMedGoogle Scholar
• Dignat-George F, Camoin-Jau L, Sabatier F et al. Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb. Haemost. 91(4), 667–673 (2004).
   PubMed Web of Science ®Google Scholar
• Bidot CJ, Jy W, Horstman LL et al. Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia. Hematology 10(6), 451–456 (2005).
   PubMed Web of Science ®Google Scholar
• Thaler J, Ay C, Weinstabl H et al. Circulating procoagulant microparticles in cancer patients. Ann. Hematol. 90(4), 447–453 (2011).
   PubMedGoogle Scholar
• Robert S, Lacroix R, Poncelet P et al. High-sensitivity flow cytometry provides access to standardized measurement of small-size microparticles – brief report. Arterioscler. Thromb. Vasc. Biol. 32(4), 1054–1058 (2012).
   PubMed Web of Science ®Google Scholar
• Lacroix R, Robert S, Poncelet P, Dignat-George F. Overcoming limitations of microparticle measurement by flow cytometry. Semin. Thromb. Hemost. 36(8), 807–818 (2010).
   PubMed Web of Science ®Google Scholar
• Basavaraj MG, Olsen JO, Østerud B, Hansen JB. Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles. Thromb. Res. 130(3), 538–546 (2012).
   PubMed Web of Science ®Google Scholar
• Amabile N, Rautou PE, Tedgui A, Boulanger CM. Microparticles: key protagonists in cardiovascular disorders. Semin. Thromb. Hemost. 36(8), 907–916 (2010).
   PubMed Web of Science ®Google Scholar
• Chandler WL, Yeung W, Tait JF. A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer. J. Thromb. Haemost. 9(6), 1216–1224 (2011).
   PubMed Web of Science ®Google Scholar
• Ay C, Dunkler D, Marosi C et al. Prediction of venous thromboembolism in cancer patients. Blood 116(24), 5377–5382 (2010).
   PubMed Web of Science ®Google Scholar
• Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111(10), 4902–4907 (2008).
   PubMed Web of Science ®Google Scholar
• Zwicker JI. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. Thromb. Res. 125(Suppl. 2), S89–S91 (2010).
   Google Scholar
• Otero R, Elias T, Montes-Worboys A et al. Effects of long-term anticoagulant therapy on levels of circulating microparticles in patients with deep venous thrombosis. Blood Coagul. Fibrinolysis 22(7), 628–629 (2011).
   PubMedGoogle Scholar